CUE HEALTH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.15 USD | +6.38% |
|
+3.16% | -7.69% |
| Apr. 09 | Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request | CI |
| Mar. 20 | Cue Health Inc. Announces Executive Changes | CI |
Financials (USD)
| Sales 2024 * | 56.98M | Sales 2025 * | 110M | Capitalization | 22.43M |
|---|---|---|---|---|---|
| Net income 2024 * | -224M | Net income 2025 * | -170M | EV / Sales 2024 * | 0.02 x |
| Net cash position 2024 * | 21.12M | Net cash position 2025 * | 16.58M | EV / Sales 2025 * | 0.05 x |
| P/E ratio 2024 * |
-0.12
x | P/E ratio 2025 * |
-0.19
x | Employees | 726 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.17% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cue Health Inc.
More recommendations
More press releases
| 1 day | +6.38% | ||
| 1 week | +3.16% | ||
| Current month | -20.47% | ||
| 1 month | -17.49% | ||
| 3 months | -32.13% | ||
| 6 months | -57.33% | ||
| Current year | -7.69% |
1 week
0.13
0.16
1 month
0.130.20
Current year
0.130.35
1 year
0.131.07
3 years
0.1322.55
5 years
0.1322.55
10 years
0.1322.55
| Managers | Title | Age | Since |
|---|---|---|---|
Clint Sever
CEO | Chief Executive Officer | 39 | 10-01-25 |
Ayub Khattak
FOU | Founder | 39 | 10-01-25 |
Aasim Javed
DFI | Director of Finance/CFO | 40 | 21-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Maria Martinez
BRD | Director/Board Member | 66 | 21-08-31 |
Joanne Bradford
BRD | Director/Board Member | 60 | 21-08-31 |
Ayub Khattak
FOU | Founder | 39 | 10-01-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 9 M€ | +5.94% | - | |
| 0.00% | 147 M€ | +5.02% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.15 | +6.38% | 229,914 |
| 24-04-22 | 0.141 | -2.83% | 506,527 |
| 24-04-19 | 0.1451 | +2.18% | 412,314 |
| 24-04-18 | 0.142 | -1.80% | 295,124 |
| 24-04-17 | 0.1446 | -0.55% | 400,757 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotes
Cue Health Inc. is a healthcare technology company. The Company is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. It offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.
Sector
Software
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.141
USD
Average target price
0.75
USD
Spread / Average Target
+431.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.69% | 22.35M | |
| +8.25% | 2,979B | |
| +2.45% | 78.63B | |
| +3.45% | 77.7B | |
| -12.94% | 53.96B | |
| -16.15% | 50.39B | |
| +25.98% | 46.4B | |
| +12.66% | 38.04B | |
| +53.11% | 33.68B | |
| -11.95% | 23.88B |
- Stock Market
- Equities
- HLTH Stock
